3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
5
Withdrawn
1
Unknown
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Motor Activity
35
Breast Neoplasms
19
Neoplasms
18
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Interventions
Oxaliplatin
47
Capecitabine
46
Fluorouracil
40
Leucovorin
30
Radiotherapy
25
Irinotecan
20
Chemoradiotherapy
14
Bevacizumab
14
Cetuximab
12
Neoadjuvant Therapy
11
Folfox protocol
11
Chemotherapy, Adjuvant
11
Laparoscopy
10
XELOX
9
Drug Therapy
9
Surgical Procedures, Operative
6
Robotic Surgical Procedures
5
Radiation
5
Mastectomy, Segmental
5
Surveys and Questionnaires
4
Radiotherapy, Intensity-Modulated
4
Panitumumab
4
Gemcitabine
4
durvalumab
3
Simvastatin
3
Magnetic Resonance Spectroscopy
3
Indocyanine Green
3
FOLFOXIRI protocol
3
tislelizumab
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Rectal Neoplasms
×
Exercise
×
Clear all
NCT05305820
2024-03-21
PANO
Dublin City University
Phase NA
Unknown
36 enrolled